BALSM MEDICAL

Balsm Alofoq Medical Company

9620StocksTadawulHealthcare

Financials

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operations
Operating Cash Flow	5.48M	5.41M	4.72M
Free Cash Flow	5.27M	-1.74M	4.53M
Capital Expenditures	-0.21M	-7.15M	-0.19M
Investing & Financing
Investing Cash Flow	-0.21M	-7.15M	-0.19M
Financing Cash Flow	9.30M	-0.32M	-1.77M
Dividends Paid	-3.00M	-0.96M	—
Operating Activities
Operating Cash Flow	5.48M	5.41M	4.72M
Net Income	4.78M	4.16M	3.51M
Change in Accounts Payable	-0.12M	0.08M	1.10M
Change in Accounts Receivable	-0.19M	0.68M	-1.75M
Change in Inventory	-215.59K	-824.41K	-701.03K
Change in Working Capital	-0.53M	-0.06M	-1.35M
Other Operating Activities	506.30K	428.47K	393.96K
Provision & Write-off of Bad Debts	-427.03K	-327.58K	774.62K
Depreciation & Amortization	1.16M	1.20M	1.38M
Miscellaneous Cash Flow Adjustments	—	—	2.98M
Investing Activities
Investing Cash Flow	-0.21M	-7.15M	-0.19M
Capital Expenditures	-0.21M	-7.15M	-0.19M
Financing Activities
Financing Cash Flow	9.30M	-0.32M	-1.77M
Common Dividends Paid	-3.00M	-0.96M	—
Issuance of Common Stock	12.65M	—	—
Short-Term Debt Issued	—	960.30K	—
Total Debt Issued	—	960.30K	—
Long-Term Debt Repaid	-355.00K	-320.00K	-330.00K
Short-Term Debt Repaid	—	—	-1.44M
Total Debt Repaid	-0.36M	-0.32M	-1.77M
Net Debt Issued (Repaid)	-0.36M	0.64M	-1.77M
Free Cash Flow & Returns
Free Cash Flow	5.27M	-1.74M	4.53M
Free Cash Flow Margin	+26.5%	-9.7%	+26.6%
Free Cash Flow Per Share	2.58	-1.18	—
Levered Free Cash Flow	3.31M	-6.34M	—
Unlevered Free Cash Flow	3.35M	-6.29M	—
Operating Cash Flow Growth	+1.3%	+14.7%	—
Net Cash Flow	14.57M	-2.06M	5.74M

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Operations
Operating Cash Flow	5.48M	5.41M	4.72M
Free Cash Flow	5.27M	-1.74M	4.53M
Capital Expenditures	-0.21M	-7.15M	-0.19M
Investing & Financing
Investing Cash Flow	-0.21M	-7.15M	-0.19M
Financing Cash Flow	9.30M	-0.32M	-1.77M
Dividends Paid	-3.00M	-0.96M	—
Operating Activities
Operating Cash Flow	5.48M	5.41M	4.72M
Net Income	4.78M	4.16M	3.51M
Change in Accounts Payable	-0.12M	0.08M	1.10M
Change in Accounts Receivable	-0.19M	0.68M	-1.75M
Change in Inventory	-215.59K	-824.41K	-701.03K
Change in Working Capital	-0.53M	-0.06M	-1.35M
Other Operating Activities	506.30K	428.47K	393.96K
Provision & Write-off of Bad Debts	-427.03K	-327.58K	774.62K
Depreciation & Amortization	1.16M	1.20M	1.38M
Miscellaneous Cash Flow Adjustments	—	—	2.98M
Investing Activities
Investing Cash Flow	-0.21M	-7.15M	-0.19M
Capital Expenditures	-0.21M	-7.15M	-0.19M
Financing Activities
Financing Cash Flow	9.30M	-0.32M	-1.77M
Common Dividends Paid	-3.00M	-0.96M	—
Issuance of Common Stock	12.65M	—	—
Short-Term Debt Issued	—	960.30K	—
Total Debt Issued	—	960.30K	—
Long-Term Debt Repaid	-355.00K	-320.00K	-330.00K
Short-Term Debt Repaid	—	—	-1.44M
Total Debt Repaid	-0.36M	-0.32M	-1.77M
Net Debt Issued (Repaid)	-0.36M	0.64M	-1.77M
Free Cash Flow & Returns
Free Cash Flow	5.27M	-1.74M	4.53M
Free Cash Flow Margin	+26.5%	-9.7%	+26.6%
Free Cash Flow Per Share	2.58	-1.18	—
Levered Free Cash Flow	3.31M	-6.34M	—
Unlevered Free Cash Flow	3.35M	-6.29M	—
Operating Cash Flow Growth	+1.3%	+14.7%	—
Net Cash Flow	14.57M	-2.06M	5.74M